Freedom Broker downgraded GoHealth (GOCO) to Hold from Buy with a price target of $1.50, down from $4.50. The company’s Q4 revenue dropped 97% year-over-year amid deterioration in Medicare Advantage commission economics, the analyst tells investors in a research note. The firm sees a “weak” 2026 for GoHealth and is “cautious” on a rebound in 2027.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GOCO: